466 related articles for article (PubMed ID: 19646978)
1. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis.
Zhen MC; Wang Q; Huang XH; Cao LQ; Chen XL; Sun K; Liu YJ; Li W; Zhang LJ
J Nutr Biochem; 2007 Dec; 18(12):795-805. PubMed ID: 17481882
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
4. Effects of ribozyme targeting platelet-derived growth factor receptor beta subunit gene on the proliferation and apoptosis of hepatic stellate cells in vitro.
Chen YX; Lu CH; Xie WF; Zhang XR; Zhang ZB; Wei LX; Jin YX; Guo YJ
Chin Med J (Engl); 2005 Jun; 118(12):982-8. PubMed ID: 15978205
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
[TBL] [Abstract][Full Text] [Related]
7. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
[TBL] [Abstract][Full Text] [Related]
8. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
Fu Y; Chen A
Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
[TBL] [Abstract][Full Text] [Related]
12. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.
Chen SW; Chen YX; Zhang XR; Qian H; Chen WZ; Xie WF
Gene Ther; 2008 Nov; 15(21):1424-35. PubMed ID: 18509379
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
15. S-allylcysteine is effective as a chemopreventive agent against porcine serum-induced hepatic fibrosis in rats.
Shinkawa H; Takemura S; Minamiyama Y; Kodai S; Tsukioka T; Osada-Oka M; Kubo S; Okada S; Suehiro S
Osaka City Med J; 2009 Dec; 55(2):61-9. PubMed ID: 20088405
[TBL] [Abstract][Full Text] [Related]
16. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
[TBL] [Abstract][Full Text] [Related]
17. Estrogen regulates insulin-like growth factor 1, platelet-derived growth factor A and B, and their receptors in the vascular wall.
Savolainen-Peltonen H; Loubtchenkov M; Petrov L; Delafontaine P; Häyry P
Transplantation; 2004 Jan; 77(1):35-42. PubMed ID: 14724432
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
[TBL] [Abstract][Full Text] [Related]
19. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.
Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Calatroni A
Chem Biol Interact; 2004 Jul; 148(3):125-38. PubMed ID: 15276869
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.
Reichenbach V; Fernández-Varo G; Casals G; Oró D; Ros J; Melgar-Lesmes P; Weiskirchen R; Morales-Ruiz M; Jiménez W
J Hepatol; 2012 Nov; 57(5):967-73. PubMed ID: 22820479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
